Back
Nektar Therapeutics Quote, Financials, Valuation and Earnings
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Buy
59
NKTR
Nektar Therapeutics
Last Price:
1.56
Seasonality Move:
-2.31%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.Nektar Therapeutics Price Quote
$1.56
-0.01 (-6.59%)
(Updated: May 4, 2024 at 6:29 AM ET)
Nektar Therapeutics Key Stats
Buy
59
Nektar Therapeutics (NKTR)
is a Buy
Day range:
$1.55 - $1.74
52-week range:
$0.41 - $1.79
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.31
P/B ratio:
2.2%
Volume:
1.1M
Avg. volume:
3M
1-year change:
96.15%
Market cap:
$288.3M
Revenue:
$90.1M
EPS:
$-1.46
How Much Does Nektar Therapeutics Make?
-
How Much Are Nektar Therapeutics's Sales Annually?
NKTR Revenues are $90.1M -
How Much Profit Does Nektar Therapeutics's Make A Year?
NKTR net income is -$276.1M
Is Nektar Therapeutics Growing As A Company?
-
What Is Nektar Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Nektar Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Nektar Therapeutics Stock Price Performance
-
Did Nektar Therapeutics Stock Go Up Last Month?
Nektar Therapeutics share price went up by 50.96% last month -
Did NKTR's Share Price Rise Over The Last Year?
NKTR share price rose by 96.15% over the past 1 year
What Is Nektar Therapeutics 52-Week High & Low?
-
What Is Nektar Therapeutics’s 52-Week High Share Price?
Nektar Therapeutics has traded as high as $1.79 over the past 52 weeks -
What Is Nektar Therapeutics’s 52-Week Low Share Price?
Nektar Therapeutics has traded as low as $0.41 over the past 52 weeks
Nektar Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Nektar Therapeutics?
-
How Much Debt Does Nektar Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Nektar Therapeutics Have?
Cash and short term investments quarterly total is $303.6M -
What Is Nektar Therapeutics’s Book Value Per Share?
Book value per share is 0.68
Is Nektar Therapeutics Cash Flow Positive?
-
What Is NKTR Cash Flow From Operations?
Cash flow from operations (TTM) is -$192.6M -
What Is Nektar Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $30K -
What Is Nektar Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $139.6M
Nektar Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
NKTR return on invested capital is -126.07% -
What Is Nektar Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -52.95% -
What Is NKTR Return On Equity?
ROE is a measure of profitability and is -126.07%
Nektar Therapeutics Earnings Date & Stock Price
-
What Is Nektar Therapeutics's Stock Price Today?
A single share of NKTR can be purchased today for 1.57 -
What Is Nektar Therapeutics’s Stock Symbol?
Nektar Therapeutics trades on the nasdaq under the ticker symbol: NKTR -
When Is Nektar Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Nektar Therapeutics is scheduled on May 9, 2024 -
When Is NKTR's next ex-dividend date?
Nektar Therapeutics's next ex-dividend date is May 4, 2024 -
How To Buy Nektar Therapeutics Stock?
You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Nektar Therapeutics Competitors
-
Who Are Nektar Therapeutics's Competitors?
Below is a list of companies who compete with Nektar Therapeutics or are related in some way:
Nektar Therapeutics Dividend Yield
Data Unavailable
Nektar Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -12.06% |
| Revenue: | 8.46% | 11.78% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 1.00 |
| Downside from Last Price: | -36.31% |